Department of Radiation Oncology (MAASTRO Clinic), Maastricht University Medical Center, GROW Research Institute, The Netherlands.
Radiother Oncol. 2010 Sep;96(3):335-8. doi: 10.1016/j.radonc.2010.07.002. Epub 2010 Jul 23.
Especially for non-small cell lung cancer, FDG-PET has in the majority of the patients led to the safe decrease of radiotherapy volumes, enabling radiation-dose escalation and, experimentally, redistribution of radiation doses within the tumor. In limited-disease small cell lung cancer, the role of FDG-PET is emerging.
尤其在非小细胞肺癌中,FDG-PET 在大多数患者中导致了放疗体积的安全减少,使放疗剂量增加成为可能,并在实验中使肿瘤内的放疗剂量重新分布。在局限期小细胞肺癌中,FDG-PET 的作用正在显现。